Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC/BCL2 double-hit B cell lymphoma.

Ravà M, D'Andrea A, Nicoli P, Gritti I, Donati G, Doni M, Giorgio M, Olivero D, Amati B.

Sci Transl Med. 2018 Jan 31;10(426). pii: eaan8723. doi: 10.1126/scitranslmed.aan8723.

PMID:
29386360
2.

Achievements and Prospects in Electrochemical-Based Biosensing Platforms for Aflatoxin M₁ Detection in Milk and Dairy Products.

Gurban AM, Epure P, Oancea F, Doni M.

Sensors (Basel). 2017 Dec 19;17(12). pii: E2951. doi: 10.3390/s17122951. Review.

3.

Transcriptional integration of mitogenic and mechanical signals by Myc and YAP.

Croci O, De Fazio S, Biagioni F, Donato E, Caganova M, Curti L, Doni M, Sberna S, Aldeghi D, Biancotto C, Verrecchia A, Olivero D, Amati B, Campaner S.

Genes Dev. 2017 Oct 15;31(20):2017-2022. doi: 10.1101/gad.301184.117. Epub 2017 Nov 15.

4.

Integrative analysis of RNA polymerase II and transcriptional dynamics upon MYC activation.

de Pretis S, Kress TR, Morelli MJ, Sabò A, Locarno C, Verrecchia A, Doni M, Campaner S, Amati B, Pelizzola M.

Genome Res. 2017 Oct;27(10):1658-1664. doi: 10.1101/gr.226035.117. Epub 2017 Sep 13.

5.

Mutual epithelium-macrophage dependency in liver carcinogenesis mediated by ST18.

Ravà M, D'Andrea A, Doni M, Kress TR, Ostuni R, Bianchi V, Morelli MJ, Collino A, Ghisletti S, Nicoli P, Recordati C, Iascone M, Sonzogni A, D'Antiga L, Shukla R, Faulkner GJ, Natoli G, Campaner S, Amati B.

Hepatology. 2017 May;65(5):1708-1719. doi: 10.1002/hep.28942. Epub 2016 Dec 30.

6.

Smyd2 is a Myc-regulated gene critical for MLL-AF9 induced leukemogenesis.

Bagislar S, Sabò A, Kress TR, Doni M, Nicoli P, Campaner S, Amati B.

Oncotarget. 2016 Oct 11;7(41):66398-66415. doi: 10.18632/oncotarget.12012.

7.

The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas.

D'Andrea A, Gritti I, Nicoli P, Giorgio M, Doni M, Conti A, Bianchi V, Casoli L, Sabò A, Mironov A, Beznoussenko GV, Amati B.

Oncotarget. 2016 Nov 8;7(45):72415-72430. doi: 10.18632/oncotarget.11719.

8.

Identification of MYC-Dependent Transcriptional Programs in Oncogene-Addicted Liver Tumors.

Kress TR, Pellanda P, Pellegrinet L, Bianchi V, Nicoli P, Doni M, Recordati C, Bianchi S, Rotta L, Capra T, Ravà M, Verrecchia A, Radaelli E, Littlewood TD, Evan GI, Amati B.

Cancer Res. 2016 Jun 15;76(12):3463-72. doi: 10.1158/0008-5472.CAN-16-0316. Epub 2016 Apr 13.

9.

Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc.

D'Artista L, Bisso A, Piontini A, Doni M, Verrecchia A, Kress TR, Morelli MJ, Del Sal G, Amati B, Campaner S.

Oncotarget. 2016 Apr 19;7(16):21786-98. doi: 10.18632/oncotarget.7846.

10.

Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis.

Sabò A, Kress TR, Pelizzola M, de Pretis S, Gorski MM, Tesi A, Morelli MJ, Bora P, Doni M, Verrecchia A, Tonelli C, Fagà G, Bianchi V, Ronchi A, Low D, Müller H, Guccione E, Campaner S, Amati B.

Nature. 2014 Jul 24;511(7510):488-492. doi: 10.1038/nature13537. Epub 2014 Jul 9.

11.

SUMOylation of Myc-family proteins.

Sabò A, Doni M, Amati B.

PLoS One. 2014 Mar 7;9(3):e91072. doi: 10.1371/journal.pone.0091072. eCollection 2014.

12.

MicroRNAs in islet immunobiology and transplantation.

Pileggi A, Klein D, Fotino C, Bravo-Egaña V, Rosero S, Doni M, Podetta M, Ricordi C, Molano RD, Pastori RL.

Immunol Res. 2013 Dec;57(1-3):185-96. doi: 10.1007/s12026-013-8436-5. Review.

PMID:
24242759
13.

A non-redundant function of cyclin E1 in hematopoietic stem cells.

Campaner S, Viale A, De Fazio S, Doni M, De Franco F, D'Artista L, Sardella D, Pelicci PG, Amati B.

Cell Cycle. 2013 Dec 1;12(23):3663-72. doi: 10.4161/cc.26584. Epub 2013 Sep 25.

14.

Dual regulation of Myc by Abl.

Sanchez-Arévalo Lobo VJ, Doni M, Verrecchia A, Sanulli S, Fagà G, Piontini A, Bianchi M, Conacci-Sorrell M, Mazzarol G, Peg V, Losa JH, Ronchi P, Ponzoni M, Eisenman RN, Doglioni C, Amati B.

Oncogene. 2013 Nov 7;32(45):5261-71. doi: 10.1038/onc.2012.621. Epub 2013 Jan 14.

15.

Inflammation-Mediated Regulation of MicroRNA Expression in Transplanted Pancreatic Islets.

Bravo-Egana V, Rosero S, Klein D, Jiang Z, Vargas N, Tsinoremas N, Doni M, Podetta M, Ricordi C, Molano RD, Pileggi A, Pastori RL.

J Transplant. 2012;2012:723614. doi: 10.1155/2012/723614. Epub 2012 May 10.

16.

Beneficial effects of ischemic preconditioning on pancreas cold preservation.

Hogan AR, Doni M, Molano RD, Ribeiro MM, Szeto A, Cobianchi L, Zahr-Akrawi E, Molina J, Fornoni A, Mendez AJ, Ricordi C, Pastori RL, Pileggi A.

Cell Transplant. 2012;21(7):1349-60.

PMID:
22305457
17.

The methyltransferase Set7/9 (Setd7) is dispensable for the p53-mediated DNA damage response in vivo.

Campaner S, Spreafico F, Burgold T, Doni M, Rosato U, Amati B, Testa G.

Mol Cell. 2011 Aug 19;43(4):681-8. doi: 10.1016/j.molcel.2011.08.007.

18.

Myc, Cdk2 and cellular senescence: Old players, new game.

Campaner S, Doni M, Verrecchia A, Fagà G, Bianchi L, Amati B.

Cell Cycle. 2010 Sep 15;9(18):3655-61. Epub 2010 Sep 15.

PMID:
20818171
19.

Chromatin association and regulation of rDNA transcription by the Ras-family protein RasL11a.

Pistoni M, Verrecchia A, Doni M, Guccione E, Amati B.

EMBO J. 2010 Apr 7;29(7):1215-24. doi: 10.1038/emboj.2010.16. Epub 2010 Feb 18.

20.

Unique vascular tumor primary arising in the liver and exhibiting histopathological features consistent with so-called polymorphous hemangioendothelioma.

Cobianchi L, Lucioni M, Rosso R, Zonta S, Fiandrino G, Alessiani M, Doni M, Ferrari A, Magrini U, Paulli M, Dionigi P.

Pathol Int. 2009 Dec;59(12):890-4. doi: 10.1111/j.1440-1827.2009.02461.x.

PMID:
20021616
21.

Cdk2 suppresses cellular senescence induced by the c-myc oncogene.

Campaner S, Doni M, Hydbring P, Verrecchia A, Bianchi L, Sardella D, Schleker T, Perna D, Tronnersjö S, Murga M, Fernandez-Capetillo O, Barbacid M, Larsson LG, Amati B.

Nat Cell Biol. 2010 Jan;12(1):54-9; sup pp 1-14. doi: 10.1038/ncb2004. Epub 2009 Dec 13.

PMID:
20010815
22.

Ischemic preconditioning improves islet recovery after pancreas cold preservation.

Hogan AR, Doni M, Ribeiro MM, Molano RD, Cobianchi L, Molina J, Zahr E, Ricordi C, Pastori RL, Pileggi A.

Transplant Proc. 2009 Jan-Feb;41(1):354-5. doi: 10.1016/j.transproceed.2008.11.003.

PMID:
19249556
23.

Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device.

Marzorati S, Bocca N, Molano RD, Hogan AR, Doni M, Cobianchi L, Inverardi L, Ricordi C, Pileggi A.

Transplant Proc. 2009 Jan-Feb;41(1):352-3. doi: 10.1016/j.transproceed.2008.09.057.

PMID:
19249555
24.

A positive role for Myc in TGFbeta-induced Snail transcription and epithelial-to-mesenchymal transition.

Smith AP, Verrecchia A, Fagà G, Doni M, Perna D, Martinato F, Guccione E, Amati B.

Oncogene. 2009 Jan 22;28(3):422-30. doi: 10.1038/onc.2008.395. Epub 2008 Nov 3.

PMID:
18978814
25.

Elemental enteral nutrition preserves the mucosal barrier and improves the trophism of the villi after small bowel transplantation in piglets.

Zonta S, Doni M, Alessiani M, Lovisetto F, Vigano J, Mazzilli M, Dominioni T, Podetta M, De Martino M, Scaglione M, Vicini E, Bottazzi A, Villa C, Morbini P, Dionigi P.

Transplant Proc. 2007 Jul-Aug;39(6):2024-7.

PMID:
17692682
26.

Prolonged survival with FK778 (malononitrilamide) monotherapy after small bowel transplantation: a large animal study.

Zonta S, Alessiani M, Viganò J, Doni M, Bardone M, Dominioni T, De Martino M, Scaglione M, Vicini E, Filisetti C, Biroli A, Bottazzi A, Villa C, Morbini P, Dionigi P.

Transplant Proc. 2007 Jul-Aug;39(6):2021-3.

PMID:
17692681
27.

Incidence of graft rejection in small bowel transplanted pigs after immunosuppression withdrawal.

Viganó J, Abbiati F, Alessiani M, Bonfichi M, Zonta S, Bardone M, Zitelli E, Cobianchi L, Doni M, Lovisetto F, Dominioni T, De Martino M, Lusona B, Arbustini E, Dionigi P.

Transplant Proc. 2006 Jul-Aug;38(6):1818-20.

PMID:
16908291
28.

Early outcome of different steroid-free regimens in small bowel transplantation: a large-animal study.

Doni M, Cobianchi L, Alessiani M, Zonta S, Abbiati F, Morbini P, Bardone M, Mazzilli M, Viganò J, De Martino M, Dominioni T, Dionigi B, Molinaro MD, Bottazzi A, Dionigi P.

Transplant Proc. 2006 Jul-Aug;38(6):1812-4.

PMID:
16908289
29.

FK778 and tacrolimus combination therapy to control acute rejection after pig intestinal transplantation.

Alessiani M, Abbiati F, Zonta S, Zitelli E, Bardone M, Cobianchi L, Viganò J, Doni M, Mazzilli M, Dominioni T, Kabiri D, Bottazzi A, Morbini P, Molinaro MD, Dionigi P.

Transplant Proc. 2006 Jul-Aug;38(6):1809-11.

PMID:
16908288
30.

FK778 does not impair intestinal allograft absorption in a preclinical model of total small bowel transplantation.

Zonta S, Doni M, Alessiani M, Abbiati F, Bardone M, Lovisetto F, Cobianchi L, Vigano J, De Martino M, Kabiri D, Dominioni T, Scaglione M, Bottazzi A, Poggi P, Dionigi P.

Transplant Proc. 2006 Jul-Aug;38(6):1805-8.

PMID:
16908287
31.

Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes.

Fiordaliso F, Cuccovillo I, Bianchi R, Bai A, Doni M, Salio M, De Angelis N, Ghezzi P, Latini R, Masson S.

Life Sci. 2006 Jun 6;79(2):121-9. Epub 2006 Jan 30.

PMID:
16445948
32.

Efficacy of malononitrilamide FK778 in a preclinical model of small bowel transplantation.

Alessiani M, Zonta S, Abbiati F, Cobianchi L, Bardone M, Zitelli E, Doni M, Viganò J, Mazzilli M, Lovisetto F, Dominioni T, Dionigi B, Lusona B, Morbini P, Molinaro MD, Dionigi P.

Transplant Proc. 2005 Jul-Aug;37(6):2719-21.

PMID:
16182793
33.

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury.

Fiordaliso F, Chimenti S, Staszewsky L, Bai A, Carlo E, Cuccovillo I, Doni M, Mengozzi M, Tonelli R, Ghezzi P, Coleman T, Brines M, Cerami A, Latini R.

Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2046-51. Epub 2005 Jan 25.

34.

Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats.

Fiordaliso F, Bianchi R, Staszewsky L, Cuccovillo I, Doni M, Laragione T, Salio M, Savino C, Melucci S, Santangelo F, Scanziani E, Masson S, Ghezzi P, Latini R.

J Mol Cell Cardiol. 2004 Nov;37(5):959-68.

PMID:
15522273
35.

[Experimental kidney transplantation: a comparison between different models].

Zonta S, Alessiani M, Abbiati F, Fayer F, Zitelli E, Bardone MC, Cobianchi I, Lovisetto F, Piccioni PF, Burroni B, Vigano J, Doni M, Dominioni T, Blangetti I, Lusona B, Morbini P, Dionigi P, Zonta A.

Minerva Chir. 2003 Oct;58(5):755-67. Italian.

PMID:
14603154
37.

Platelet activation and modulation of the induction of nitric oxide synthase in the conscious rat.

Picunio S, Simioni M, Doni MG.

Life Sci. 1999;65(14):1463-75.

PMID:
10530798
38.

Chemical synthesis and structural characterization of the RGD-protein decorsin: a potent inhibitor of platelet aggregation.

Polverino de Laureto P, Scaramella E, De Filippis V, Marin O, Doni MG, Fontana A.

Protein Sci. 1998 Feb;7(2):433-44.

39.

Inhibition of platelet activation by MM-706, a stable carbacyclin analog, in the conscious rat.

Meggiato C, Padoin E, Ragazzi E, Chinellato A, Doni MG.

Gen Pharmacol. 1997 Feb;28(2):251-5.

PMID:
9013203
40.

Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.

Padoin E, Alexandre A, Cavallini L, Polverino de Laureto P, Rao GH, Doni MG.

Arch Biochem Biophys. 1996 Sep 15;333(2):407-13.

PMID:
8809080
41.

Pharmacological properties of MM-706, a new prostacyclin derivative.

Ragazzi E, Chinellato A, Lille U, Lopp M, Doni MG, Fassina G.

Gen Pharmacol. 1995 Jul;26(4):703-9.

PMID:
7635245
42.
43.

[Light chain deposition disease].

Terzani E, Alterini B, Doni M, Lampronti V, Lusini C, Fazzini G.

Ann Ital Med Int. 1994 Apr-Jun;9(2):100-4. Italian.

PMID:
7917761
44.
45.

Platelet activation by diacylglycerol or ionomycin is inhibited by nitroprusside.

Doni MG, Deana R, Padoin E, Ruzzene M, Alexandre A.

Biochim Biophys Acta. 1991 Sep 24;1094(3):323-9.

PMID:
1655043
46.

Nitrovasodilators and cGMP inhibit human platelet activation.

Doni MG, Alexandre A, Padoin E, Bertoncello S, Deana R.

Cardioscience. 1991 Sep;2(3):161-5.

PMID:
1660321
47.

Platelet responses promoted by the activation of protein kinase C or the increase of cytosolic Ca2+ are potentiated by adrenaline. Effects of cAMP and staurosporine.

Zoccarato F, Ruzzene M, Cavallini L, Doni MG, Francesconi MA, Deana R, Alexandre A.

Biochim Biophys Acta. 1991 Mar 19;1092(1):72-8.

PMID:
1849018
48.

Cyclic GMP and nitroprusside inhibit the activation of human platelets by fluoroaluminate.

Deana R, Ruzzene M, Doni MG, Zoccarato F, Alexandre A.

Biochim Biophys Acta. 1989 Nov 20;1014(2):203-6.

PMID:
2573392
49.

The role of the leukocyte adherence inhibition (LAI), CA 19-9, and tissue polypeptide antigen (TPA) tests in the diagnosis of pancreatic cancer.

Meduri F, Doni MG, Merenda R, Bizzarini M, Neri D, Gerunda GE, Maffei Faccioli A.

Cancer. 1989 Sep 1;64(5):1103-6.

PMID:
2667748
50.

[The L.A.I. test and tumor markers (Ca 19-9 and TPA) in the diagnosis of pancreatic carcinoma].

Meduri F, Bizzarini M, Diana F, Merenda R, Gerunda GE, Doni MG, Maffei Faccioli A.

Minerva Chir. 1989 Aug 31;44(15-16):1777-81. Italian.

PMID:
2682370

Supplemental Content

Support Center